A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil

By Hellstrom W.J.G.   Bennett A.H.   Gesundheit N.   Kaiser F.E.   Lue T.F.   Padma-Nathan H.   Peterson C.A.   Tam P.Y.   Todd L.K.   Varady J.C.   Place V.A.  

Urology, Vol. 48, Iss. 6, 1996-12 ,pp. : 851-856

Elsevier

Access to resources Recommend Favorite

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia

By Elhilali M.M.   Ramsey E.W.   Barkin J.   Casey R.W.   Boake R.C.   Beland G.   Fradet Y.   Trachtenberg J.   Orovan W.L.   Schick E.   Klotz L.H.  

Urology, Vol. 47, Iss. 3, 1996-03 ,pp. : 335-342

Elsevier

Access to resources Recommend Favorite

Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study - endogtenous bimodal modulators of the GABA receptor: mechanism of action and physiological significance

By Reiter W.J.   Pycha A.   Schatzl G.   Pokorny A.   Gruber D.M.   Huber J.C.   Marberger M.  

Urology, Vol. 53, Iss. 3, 1999-03 ,pp. : 590-594

Elsevier

Access to resources Recommend Favorite

Efficacy of sildenafil in an open-label study as a continuation of a double-blind study in the treatment of erectile dysfunction after radiotherapy for prostate cancer

By Incrocci L.   Hop W.C.J.   Slob A.K.  

Urology, Vol. 62, Iss. 1, 2003-07 ,pp. : 116-120

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of doxazosin in benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies

By Roehrborn C.G.   Siegel R.L.  

Urology, Vol. 48, Iss. 3, 1996-09 ,pp. : 406-415

Elsevier

Access to resources Recommend Favorite